Benzodiazepine Withdrawal Isn’t About Dose—It’s About Stress-System Activation

Week 1 of the Withdrawal Biology Series

Dose changes alone cannot explain benzodiazepine withdrawal. In our 39-patient dataset, reported symptoms spanned five broad stress-responsive domains rather than tracking dose in any simple linear way. These domains are an organizing framework for describing complex symptom patterns — not established biological subtypes.

---

Why dose isn’t the explanation

GABA is the brain’s primary safety signal.

When GABA restraint becomes unstable—whether from tolerance, interdose withdrawal, or tapering—the brain interprets this as a loss of safety. This triggers activation of multiple stress-responsive systems:

• CRH–adrenergic circuits—internal tremor, morning surges

• Autonomic and vagal pathways—HR/BP swings, dizziness

• Microglial and excitatory-neuroinflammatory signaling—burning, nerve pain

• Mast-cell and sensory reactivity—flushing, rashes, food/environment triggers

• Cerebellar/motor stress loops—akathisia, balance shifts, motor pressure

Withdrawal variability arises from how each of these stress subsystems responds, not from the milligram dose on the calendar.

What this means for understanding withdrawal

The heterogeneity of benzodiazepine withdrawal is not arbitrary. It appears to vary with how each person's stress-responsive systems behave.

This perspective supports more individualized approaches to tapering and stabilization — approaches informed by stress physiology rather than by dose alone.